These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26485239)

  • 1. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
    Martires KJ; Ra S; Abdulla F; Cassarino DS
    Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA; Feldman AL; Magro C
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
    De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
    J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Kempf W
    Surg Pathol Clin; 2014 Jun; 7(2):203-28. PubMed ID: 26837199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
    Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
    J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.
    Nasit JG; Patel SC
    Indian J Dermatol; 2015; 60(4):373-7. PubMed ID: 26288406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
    Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
    Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ lymphomatoid papulosis and its differential diagnosis.
    Magro CM; Crowson AN; Morrison C; Merati K; Porcu P; Wright ED
    Am J Clin Pathol; 2006 Apr; 125(4):490-501. PubMed ID: 16627259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.
    Wang W; Cai Y; Sheng W; Lu H; Li X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):96-104. PubMed ID: 24332333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.
    Kempf W; Kazakov DV; Schärer L; Rütten A; Mentzel T; Paredes BE; Palmedo G; Panizzon RG; Kutzner H
    Am J Surg Pathol; 2013 Jan; 37(1):1-13. PubMed ID: 23026936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.